Enhanced Expression of the Voltage-Dependent Anion Channel 1 (VDAC1) in Alzheimer's Disease Transgenic Mice: An Insight into the Pathogenic Effects of Amyloid-β
Mar Cuadrado‐Tejedor(University of Copenhagen), Alberto Pérez‐Mediavilla(Navarre Institute of Health Research)
Cited by 137
Related Papers
Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease
|British Journal of Pharmacology|2011|210
A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice
|Neuropsychopharmacology|2016|104
Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease
|Frontiers in Aging Neuroscience|2019|46
Maternal imprinting on cognition markers of wild type and transgenic Alzheimer’s disease model mice
|Scientific Reports|2018|18